The global Fish Vaccine market was valued at US$ 249.20 Mn in 2022 and is forecast to reach a value of US$ 413.41 Mn by 2030 at a CAGR of 6.5% between 2022 and 2030.
The market for fish vaccines worldwide is predicted to be worth US$ 249.20 billion by vaccine type (recombinant vector vaccines, killed vaccine, conjugate vaccine, inactivated vaccine, subunit vaccine, attenuated vaccine, and toxoid vaccine), indication (furunculosis, yersiniosis, enteric septicemia), route of administration (injection, oral, immersion, and spray), and region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) from 2022 to 2030.
Request FREE Sample Report (Including Full TOC, Table & Figures) @
https://www.coherentmarketinsights.com/insight/request-sample/5184
Product launches engage the market’s players, which is expected to fuel market growth over the course of the projected period. A good example is the injectable vaccine ICTHIOVAC VR/PD versus pasteurellosis and vibriosis in sea bass, which was released in 2018 by the global pharmaceutical and biotechnology business HIPRA. The company also made ICTHIOVAC VR/PD for sea bream and sea bass available in Tunisia, Spain, Italy, France, and Portugal.
Over the course of the forecast period, rising government initiatives to promote aquaculture are anticipated to fuel market expansion for fish vaccines. For instance, the European Union began a project in April 2022 to expand Morocco’s aquaculture industry, coupled with a grant of US$ 269,670. The National Agency for the Development of Aquaculture in Morocco and the Ministry of Agriculture of France jointly manage the project (ANDA).
Impact of Coronavirus
Globally, the COVID-19 pandemic has had an impact on a number of markets. The COVID-19 pandemic has had three primary effects on supply and demand for healthcare products: it has directly influenced supply and demand, it has disrupted distribution systems, and it has had a financial impact on businesses and markets.
Due to a decline in fisheries productivity, COVID-19 has a substantial influence on the global market for fish vaccines. For instance, the COVID-19 had a tremendously huge influence on the aquaculture and seafood businesses, and the people who rely only on seafood had to go through a lot of troubles, according to the Springer journal in August 2021. The food supply chain was further impeded by numerous measures adopted to counteract the pandemic’s detrimental impacts. The aquaculture business was severely harmed by the challenges brought on by the constrained acquisition of inputs as a result of the unfair exports.
Download PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/5184
Key Takeaways
Over the forecast period, the global fish vaccine market is anticipated to see a CAGR of 6.5%. (2022-2030). A significant portion of the market is anticipated to be accounted for by North America during the forecast period (2022–2030), as a result of growing government initiatives to boost fish and seafood production. For instance, the U.S. Department of Agriculture (USDA) announced in February 2022 that the Seafood Processors Pandemic Response and Safety Block Grant Program would receive a grant investment of US$ 50 million to help processing vessels (SPRS), seafood processors, and processing facilities.
The market for fish vaccines worldwide is projected to grow at a CAGR of 6.5% during the forecast period. (2022-2030). North America is estimated to account for a sizable percentage of the market during the forecast period (2022-2030) due to expanding government initiatives to increase fish and seafood production. For instance, the US Department of Agriculture (USDA) stated in February 2022 that it will invest US$50 million in the Safety Block Grant Program and Seafood Processors Pandemic Response to support processing boats (SPRS), seafood processors, and processing facilities.
NISSEIKEN CO., LTD., HIPRA, Aqua Vet S.A., VETERQUIMICA SA, KBNP, INC., Ictyogroup, Zoetis Inc., Kyoto Biken Laboratories, Inc., Merck & Co., Inc., Vaxxinova International BV, and Barramundi Group are a few of the prominent companies in the worldwide fish vaccine market.
Reasons to buy this Fish Vaccine Market Report
☑ It attempts an analysis of the competing scenario.
☑ The current and exceptional product revenue market.
☑ An in-depth data on the regional investigation and competitive landscape structure.
☑ It benefits in creating an awareness of the important key product segments.
☑ The marketing strategies, opportunities, and development factors are explained.
☑ Fish Vaccine market size estimation and recent advancements in the industry are explained.
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5184
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccine Type
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PESTLE Analysis
- Industry Trends
- Key Highlights
- Epidemiology
- Reimbursement Scenario
- Regulatory Scenario
- Product Launch and Approvals
- Acquisition and Collaboration Scenario
- Market Dynamics
- Global Fish Vaccine Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Fish Vaccines
- Impact of COVID-19 on the overall Healthcare Sector
- Global Fish Vaccine Market, By Vaccine Type, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
- Killed Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Inactivated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Attenuated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Toxoid Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Subunit Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Conjugate Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Recombinant Vector Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Introduction
- Global Fish Vaccine Market, By Indication, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
- Furunculosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Vibriosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Yersiniosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Enteric septicaemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Introduction
- Global Fish Vaccine Market, By Route of Administration, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
- Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Immersion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Spray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Introduction
- Global Fish Vaccine Market, By Region, 2017-2030 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Market Size and Forecast, By Vaccine Type, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Vaccine Type, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Vaccine Type, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Vaccine Type, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Vaccine Type, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Vaccine Type, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Indication, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017-2030 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- HIPRA*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- VETERQUIMICA SA
- Ictyogroup
- Kyoto Biken Laboratories, Inc.
- Vaxxinova International BV
- Barramundi Group
- Merck & Co., Inc.
- Zoetis Inc.
- KBNP, INC.
- Aqua Vet S.A.
- NISSEIKEN CO., LTD
- HIPRA*
- Company Profiles
*Key pointers provided are also applicable to other companies covered in the scope of the report.
- Section
- Research Methodology
- About us
- Contact
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact us:
Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com